InvestorsHub Logo
Followers 19
Posts 6016
Boards Moderated 3
Alias Born 05/23/2019

Re: HopeSkeptic post# 10898

Monday, 08/19/2019 7:44:33 AM

Monday, August 19, 2019 7:44:33 AM

Post# of 22001
HopeS. This article should give you insights into the FDA regulatory actions you seem to be concerned about being so overweight in CWEB stock you understand. Also check out Mr. Tomc’s comments and insights. My advice, contact your CEO and ask for GRAS. This is why CW needs it so badly you understand. Have Mercy Wolf Ahooooooo


“Expressing a view that he said is “broadly shared by the marketplace,” Tomc said hemp-derived CBD was marketed before any “substantial clinical investigations” began and were publicized.”

https://www.naturalproductsinsider.com/regulatory/cv-sciences-ventures-food-space-following-cbd-safety-assessment

Tomc also stated :

“The investigations that were publicized were not substantial, due to being limited in number and preliminary in nature, thereby rendering the IND [investigational new drug] preclusion inapplicable,” he added. “Furthermore, the IND preclusion isn’t a new conversation in the dietary supplement industry. Many ingredients such as trans-resveratrol, P5P [pyridoxal-5-phosphate] and DHEA [dehydroepiandrosterone] have been subject to the same scrutiny and continue to be sold as dietary supplements.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CWBHF News